A pilot study was conducted in Kazakhstan to assess the effects of introducing the Xpert MTB/RIF (Xpert) diagnostic test to detect tuberculosis (TB) and rifampicin resistant TB among individuals at risk of multidrug-resistant (MDR-)TB.
Effect of Introducing Xpert MTB/RIF in Kazakhstan
![nieuwsbericht 3](https://www.kncvtbc.org/uploaded/2015/09/nieuwsbericht-3-1380x0-c-default.png)